Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05568420 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05568420 · ClinicalTrials.gov record · last posted 2026-08-20

A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)

StatusActive, Not Recruiting
PhaseNot specified
Started2022-09-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study will collect biospecimens (including blood, tissue, and stool samples) and health information to create a database-a type of collection of information-for better understanding young onset colorectal cancer (YOCRC). The study will include both people with YOCRC and healthy people.

Protocol amendment history 4 changes detected by DataLookout

2026-08-21
Enrollment closed, study ongoing
2026-08-21
Enrollment reduced: 160 → 41 participants
2026-08-21
Primary completion pushed: 2026-09 → 2027-09
2026-08-21
Completion pushed: 2026-09 → 2027-09
Trial Details
NCT Number NCT05568420
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Shaare Zedek Medical Center, Technion, Israel Institute of Technology
Conditions Colorectal Cancer
Enrollment 41 participants
Start Date 2022-09-30
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-20